Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
53 | N-linked (GlcNAc...) asparagine | |||
86 |
|
|
||
130 | N-linked (GlcNAc...) asparagine | |||
161 |
|
|
||
396 | N-linked (GlcNAc...) asparagine |
|
||
576 |
|
|
||
580 | N-linked (GlcNAc...) asparagine | |||
592 |
|
|
||
|
|
Pathway Name | Organism |
---|---|
Biosynthesis of DHA-derived SPMs | Homo sapiens |
Biosynthesis of DPAn-3 SPMs | Homo sapiens |
Biosynthesis of EPA-derived SPMs | Homo sapiens |
Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | Homo sapiens |
Interleukin-10 signaling | Homo sapiens |
Interleukin-4 and Interleukin-13 signaling | Homo sapiens |
Nicotinamide salvaging | Homo sapiens |
Synthesis of 15-eicosatetraenoic acid derivatives | Homo sapiens |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110165 | Charcot-Marie-Tooth disease type 2E | |
DOID:0110166 | Charcot-Marie-Tooth disease axonal type 2H | |
DOID:0110167 | Charcot-Marie-Tooth disease axonal type 2K | |
DOID:0110168 | Charcot-Marie-Tooth disease type 2Y | |
DOID:0110169 | Charcot-Marie-Tooth disease axonal type 2P | |
DOID:0110170 | Charcot-Marie-Tooth disease axonal type 2Q | |
DOID:0110173 | Charcot-Marie-Tooth disease axonal type 2U | |
DOID:0110174 | Charcot-Marie-Tooth disease axonal type 2L | |
DOID:0110175 | Charcot-Marie-Tooth disease axonal type 2O | |
DOID:0110177 | Charcot-Marie-Tooth disease axonal type 2N |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024